Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...

Cold weather intensifies joint pain for Osteoarthritis sufferers due to reduced blood flow. While OA is irreversible, ...

More patients are presenting to emergency departments with infected knees after being injected with hyaluronic acid.

Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Cipla partners with Stempeutics to launch Ciplostem, a new therapy for Knee Osteoarthritis approved by DCGI. Targets disease ...

An orthopaedic surgeon explains how treatment innovations are supporting knee health and speeding up recovery.

Shoulder issues are more common in women, especially after age 40. They are also associated with medical conditions such as ...

Home > Press release: Knee joint osteoarthritis replicated in ... Frankfurt UAS develops in vitro model for investigating early stages of the disease ...

An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...

Orthotics and exercise outperform medication: simple therapies offer greater relief for knee osteoarthritis with fewer risks.